Back to News
Market Impact: 0.15

Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort

Healthcare & BiotechCompany FundamentalsClinical / Regulatory Events

Reflow Medical announced that the Medical University of Graz enrolled the first patient in its DEEPER CHALLENGE clinical trial. This marks an early clinical-stage milestone, typically supportive for the program’s progress, though it is not yet indicative of efficacy or commercial timelines.

Analysis

Reflow Medical announced that the Medical University of Graz enrolled the first patient in its DEEPER CHALLENGE clinical trial. This marks an early clinical-stage milestone, typically supportive for the program’s progress, though it is not yet indicative of efficacy or commercial timelines.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15